Change of Name

Eden Biosolutions PLC

01 October 2026

 

1 October 2026

 

Eden Research plc

(“Eden” or “Company)

Change of Name

Eden Research plc (AIM: EDEN), a leader in sustainable biopesticide and biocontrol technology, announces that, further to the announcement made on 29 September 2026, the change of the Company's name to Eden BioSolutions plc has been registered at Companies House, taking effect from 30 September 2026.

Trading in the Company's ordinary shares under the new company name is expected to commence at 8.00 a.m. on 1 October 2026.

The Company's TIDM (EDEN), ISIN (GB0001646941), SEDOL (0164694) and Legal Entity Identifier (LEI) (213800ZWTYTVQQSM3J85) remain unchanged. The Company's website and AIM Rule 26 disclosures will remain available at the existing website address pending the launch of a new corporate website, which is expected in November 2026. Further details will be announced in due course.

Shareholder documents of title will be unaffected by the change of name and existing share certificates should be retained and remain valid. Any new share certificates to be issued will bear the new name, Eden BioSolutions plc.

For further information contact:

Eden BioSolutions plc			www.edenresearch.com
Sean Smith, Chief Executive Officer			Via Walbrook PR
Alex Abrey, Chief Financial Officer
Cavendish Capital Markets Limited (Nominated advisor and joint broker)				Tel: [phone]
Giles Balleny / Elysia Bough (Corporate Finance)
Harriet Ward (Corporate Broking) / Dale Bellis (Sales)
Oberon Capital (Joint Broker)			Tel: [phone]
Nick Lovering / Mike Seabrook / Adam Pollock
Walbrook PR (Media Relations & Investor Relations)		Tel: [phone] or [e-mail]
Paul McManus / Nick Rome / Anna Dunphy

Notes to Editors:

Eden BioSolutions is the only UK-listed company focused on biopesticides for sustainable agriculture. It develops and supplies innovative biopesticide products and natural microencapsulation technologies to the global crop protection, animal health and consumer products industries.

Eden's products are formulated with terpene active ingredients, based on natural plant defence metabolites. To date, they have been primarily used on high-value fruits and vegetables, improving crop yields and marketability, with equal or better performance when compared with conventional pesticides. Eden has three products currently on the market:

Based on plant-derived active ingredients, Mevalone® is a foliar biofungicide which initially targets a key disease affecting grapes and other high-value fruit and vegetable crops.  It is a useful tool in crop defence programmes and is aligned with the requirements of integrated pest management programmes. It is approved for sale in a number of key countries whilst Eden and its partners pursue regulatory clearance in new territories thereby growing Eden's addressable market globally.

Cedroz™ is a bionematicide that targets free living nematodes which are parasitic worms that affect a wide range of high-value fruit and vegetable crops globally.  Cedroz is registered for sale on two continents and Eden's commercial collaborator, Eastman Chemical, is pursuing registration and commercialisation of this important new product in numerous countries globally.

Eden's seed treatment product (approval expected in 2026), Ecovelex was developed to safely tackle crop destruction caused by birds - a major cause of losses in maize and other crops. Ecovelex works by creating an unpleasant taste or odour that repels birds, leaving the seeds safely intact and the birds unaffected and free to find alternative food sources. The product is based on Eden's plant-derived chemistry, registered in the EU, US and elsewhere, and formulated using Eden's Sustaine® microencapsulation system.

Eden's Sustaine® encapsulation technology is used to harness the biocidal efficacy of naturally occurring chemicals produced by plants (terpenes) and can also be used with both natural and synthetic compounds to enhance their performance and ease-of-use. Sustaine microcapsules are naturally-derived, plastic-free, biodegradable micro-spheres derived from yeast. It is one of the only viable, proven and immediately registerable solutions to the microplastics problem in formulations requiring encapsulation.

Eden was admitted to trading on AIM on 11 May 2012 and trades under the symbol EDEN. It was awarded the London Stock Exchange Green Economy Mark in January 2021, which recognises London-listed companies that derive over 50% of their total annual revenue from products and services that contribute to the global green economy. Eden derives 100% of its total annual revenues from sustainable products and services.

For more information about Eden, please visit:  www.edenresearch.com.

Follow Eden on LinkedIn, Twitter and YouTube. 

 

END